先端ロボット・内視鏡手術学

Medicine & Life Sciences

1. Abdomen 6%
2. Adenocarcinoma 5%
3. Adjuvant Chemotherapy 5%
4. Anastomotic Leak 5%
5. Arteries 6%
6. Capsules 8%
7. Carcinoma 20%
8. Chemoradiotherapy 9%
9. Cisplatin 5%
10. Cohort Studies 9%
11. Colonic Neoplasms 6%
12. Colorectal Neoplasms 11%
13. Colostomy 5%
14. Dihydrouracil Dehydrogenase (NADP) 8%
15. Dissection 15%
16. Drug Therapy 14%
17. Esophageal Neoplasms 10%
18. Esophageal Squamous Cell Carcinoma 6%
19. Esophagectomy 26%
20. Esophagus 6%
21. Fluorouracil 8%
22. Gastrectomy 100%
23. Gastroenterostomy 7%
24. Gastrointestinal Stromal Tumors 11%
25. Hepatectomy 5%
26. Hepatic Veins 11%
27. Imatinib Mesylate 5%
28. Japan 19%
29. Laparoscopy 26%
30. Liver 13%
31. Lymph Node Excision 34%
32. Lymph Nodes 12%
33. Margins of Excision 6%
34. Minimally Invasive Surgical Procedures 9%
35. Morbidity 7%
36. Multicenter Studies 5%
37. Neoplasm Metastasis 14%
38. Neoplasms 20%
39. Operative Time 8%
40. Orotate Phosphoribosyltransferase 20%
41. Pancreatectomy 12%
42. Pancreatic Fistula 5%
43. Pancreatic Neoplasms 5%
44. Pancreaticoduodenectomy 11%
45. Pancreaticojejunostomy 5%
46. Pathologic Constriction 5%
47. Postoperative Complications 8%
48. Prolapse 5%
49. Prone Position 6%
50. Propensity Score 7%
51. Rectal Neoplasms 29%
52. Rectum 6%
53. Recurrence 16%
54. Retrospective Studies 10%
55. Robotics 50%
56. Small Intestine 5%
57. Stomach 35%
58. Stomach Neoplasms 73%
59. Surgeons 11%
60. Survival 5%
61. Survival Rate 5%
62. Therapeutics 6%
63. Thymidylate Synthase 7%
64. Transanal Endoscopic Surgery 5%
65. Vocal Cord Paralysis 6%